29
/
en
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
2162538
179119
2
Create
Public Timelines
Library
FAQ
For education
Cabinet
For educational institutions
For teachers
For students/pupils
jan 1, 2004 - FDA approves first "anti-angiogenic" drug, bevacizumab
Description:
Bavacizumab is the first of a new generation of targeted drugs that attacked cancer by blocking blood flow to the tumors.
Added to timeline:
16 Nov 2018
0
0
251
Cancer Dates
Date:
jan 1, 2004
Now
~ 20 years ago